TSX Biotech Stocks to Watch (TSX.V: QPT) (TSX:ONC; NASDAQ:ONCY) (TSX.V:IMV) AEZS) (TSX: AEZ).; Innovative Ovarian Cancer Treatments

New York, NY - Point Roberts, WA - March 26, 2014 (Investorideas.com Newswire) Investorideas.com, a global news source for leading sectors including biotech and pharma issues a sector snapshot of TSX biotech stocks targeting ovarian cancer as part of their product pipeline. Stocks mentioned include Quest PharmaTech Inc. (TSX.V: QPT), Oncolytics (TSX:ONC; NASDAQ:ONCY) , Immunovaccine, Inc. (TSX.V:IMV) and Aeterna Zentaris Inc. (AEZS) (TSX: AEZ).

There are 17,000 women living with ovarian cancer in Canada. It is estimated that this year in Canada, 2,600 women will be newly diagnosed with ovarian cancer. Ovarian cancer is the 5th most common cancer for women and is the most fatal women's cancer, says Ovarian Cancer Canada.
According to reported statistics, more than 22,000 women are diagnosed with ovarian cancer in the United States annually, and more than 12,000 die each year.
In February news reports said, "As many as one in four hundred women test positive for the BRCA-1 gene, often called the "breast cancer gene."
They have not only a significantly increased risk for breast cancer, but also for ovarian cancer.”
http://www.wlbz2.com/story/news/nation/2014/03/23/6788983/
Leading U.S. biotech stocks have had a massive bull run this year, although recently the sector has had a correction on concerns of valuations. However some of the smaller microcap stocks have not seen the same volatile trading patterns.
For investors looking at TSX biotech stocks and life sciences stocks, a recently released interview in the Life Sciences Report (TSLR) with Roadmap Capital explains the difference in valuations in US and TSX biotech stocks best.
"TLSR: Why invest primarily in Canadian companies? If you were exclusively a resource investor, and looking for deep value as well as growth, this is understandable, but in the life sciences sector, where the goal is huge growth, why limit yourself to Canadian stocks? Is it about tax advantages? National pride?
HC: I should point out that the new fund has made investments in the U.S. already, and will continue to do so. But we are focusing primarily in Canada. Frankly, it's about where we see the best opportunities and risk/reward ratio. There's no shortage of innovation in Canada, but the long, drawn-out bear market that the Canadian tech and healthcare sectors went through for much of the last decade has left many interesting companies valued at levels far below what is available in other countries. To give you an example, we're putting money into a company with a $2.5M pre-money valuation. Comparable companies in the States would be valued in the $30-40M pre-money range currently. And we have invested a small amount of money into a private stem cell company called Hemostemix. It is raising money at a $25M pre-money valuation, when its best public comparables in the U.S. trade at valuations in the $200—400M range. It comes down to where we see the best valuation opportunities and risk/reward for our investors right now. - "
Source : http://www.equities.com/editors-desk/stocks/healthcare/apply-market-savvy-to-bear-market-debris-uncover-biotech-treasures-cleland-and-ireland cPhase 2 biotech tsx ovarian cancer co's
Sector Snapshot : Ovarian Cancer Treatment
Quest PharmaTech Inc.'s ( TSX.V: QPT).lead product, Oregovomab is currently completing a phase II clinical trial in both Italy and the U.S., is used in combination with standard chemotherapy in ovarian cancer patients. It is also being tested in combination with other immunotherapeutic agents for use in treating pancreatic cancer patients.
From a previous interview with Investorideas.com, Madi R. Madiyalakan, Ph.D., Chief Executive Officer, said "Our technology is focused on the immunotherapy of cancer. We utilize tumor directed monoclonal antibodies to activate the specific immunity; however we recognize that successful therapy requires orchestrated combination with chemotherapy, photodynamic therapy and select additional immune modulators or adjuvants. Our lead product, Oregovomab, which is currently completing a phase II clinical trial in both Italy and the U.S., is used in combination with standard chemotherapy in ovarian cancer patients. We are also initiating a clinical trial using Oregovomab in combination with an immuno-adjuvant, Hiltonol® (TLR3 agonist), with standard chemotherapy. Oregovomab is also being tested in combination with other immunotherapeutic agents for use in treating pancreatic cancer patients. Our pipeline also includes proprietary antibodies against other cancer markers, most notably MUC1, PSA and HER2. We expect to advance our MUC1 targeting antibody into the clinic in the coming year. MUC1 expressing cancers include many commonly occurring solid cancers such as breast, pancreatic and lung cancers. "
Six month chart:
Oncolytics (TSX: ONC; NASDAQ:ONCY)
Oncolytics Biotech Inc. is focused on the development of oncolytic viruses for use as cancer therapeutics. The Company’s lead product, REOLYSIN®, a proprietary formulation of the human reovirus, is currently in late stage (Phase III) clinical testing in head and neck cancers. REOLYSIN® has been utilized in nearly thirty clinical trials including translational, Phase I, Phase II (single arm and randomized), and Phase III studies in a broad range of cancer indications. Ovarian cancer : OG-0186H (NCI / GOG Trial) Phase II Intravenous Administration of REOLYSIN® in Combination with Paclitaxel for Patients with Persistent or Recurrent Ovarian, Fallopian Tube or Primary Peritoneal Cancer US- status is ongoing.
Six month chart:
Immunovaccine, Inc. (TSX.V: IMV)
According to the company's financial report released March 17th, "During 2013, scientists provided compelling evidence that the human immune system could be trained to destroy cancer cells," said Dr Marc Mansour, chief operating officer. "These findings support the idea that immunotherapies have the potential to shift cancer from a life threatening disease to a chronic and manageable condition.
"Several large pharmaceutical companies also announced during the year that vaccines will play an important role in the development of their cancer therapy programs. These industry trends parallel our own approach to the development of therapeutic cancer vaccines. With our planned trials in ovarian cancer, glioblastoma and breast cancer expected to begin this year, IMV is well placed to participate in this rapidly evolving industry."
Highlights of 2013 and First Quarter of 2014

• DPX-Survivac - Positive data from Immunovaccine's completed Phase I study were presented at multiple venues throughout the year, including the 2013 ASCO annual meeting. We believe that these findings represent some of the strongest immune responses against a cancer target seen to date.

Based on these promising data, Canada's NCIC Clinical Trials Group (NCIC) agreed to sponsor and conduct a randomized Phase II study of DPX-Survivac in patients with advanced ovarian cancer. We expect this study to be initiated in 2014 with results available in 2017. Immunovaccine also signed an agreement with the University of Rome for a multicenter Phase II study of DPX-Survivac in glioblastoma patients. The study is expected to begin in 2014 and its costs will be assumed by this University.

• DPX-0907 - Immunovaccine agreed to allow use of DPX-0907 in a Phase I/II study of breast and ovarian cancer patients at the Busto Arsizio Hospital in Italy. The study, which will be funded by Busto Arsizio, is expected to be initiated in 2014.

Six month chart :
Aeterna Zentaris Inc. (AEZS) (TSX: AEZ)  is a biopharmaceutical company engaged in developing novel treatments in oncology and endocrinology. Their pipeline includes Zoptarelin doxorubicin for Ovarian and prostate cancer, currently in Phase 11. Zoptarelin doxorubicin is a targeted cytotoxic peptide conjugate which is a hybrid molecule composed of a synthetic peptide carrier and a well-known cytotoxic agent, doxorubicin. The design of this product allows for the specific binding and selective uptake of the cytotoxic conjugate by the LHRH receptor-positive tumors. The binding of conjugate molecule zoptarelin doxorubicin to cancerous cells that express these receptors results in its accumulation in the malignant tissue. This binding is followed by internalization and retention of the cytotoxic drug, doxorubicin, in the cells. Therefore, since they target specific cells, cytotoxic conjugates are postulated to be more effective and have less side-effects than the respective non-conjugated/non-linked cytotoxic agents in inhibiting tumor growth.
Six month chart
TSX Life Sciences Snapshot
Life Sciences Markets at a Glance – YTD February 28, 2014

February   2014	TSX Venture (TSXV)	TSX	TSXV and TSX
Number of Issuers	69	39	108
QMV (C$)	2,153,038,500	63,319,048,526	65,472,087,027
New Listings	2	-	2
Equity Capital Raised (C$)	126,738,564	10,823,900	137,562,464
Number of Financings	18	2	20
Volume Traded	295,773,521	238,949,246	534,722,767
Value Traded (C$)	162,114,369	3,263,237,459	3,425,351,827
# of Trades	82,324	277,538	359,862

http://www.tmx.com/en/listings/sector_profiles/life_sciences.html
According to the TSX, nearly $3 billion of equity capital was raised by life sciences companies on TSX and TSXV in 2013.
About InvestorIdeas.com:
InvestorIdeas.com is a global news source for investors following leading business sectors including biotech, tech, mining, mobile, energy, water, defense and security, renewable energy and Latin American stocks.
Sign up for our free news alerts
http://www.investorideas.com/Resources/Newsletter.asp
Become an Investorideas.com Member http://www.investorideas.com/membership/
Disclaimer/ Disclosure: The Investorideas.com newswire is a third party publisher of news and research as well as creates original content as a news source. Original content created by investorideas is protected by copyright laws other than syndication rights. Investorideas is a news source on Google news and Linkedintoday plus hundreds of syndication partners. Our site does not make recommendations for purchases or sale of stocks or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investment involves risk and possible loss of investment. This site is currently compensated by featured companies, news submissions, content marketing and online advertising. Contact each company directly for press release questions. Disclosure is posted on each release if required but otherwise the news was not compensated for and is published for the sole interest of our readers. Disclosure: QPT.V, a public company, has engaged Investorideas.com for public relations services for four thousand a month retainer fee.
More disclaimer info: http://www.investorideas.com/About/Disclaimer.asp
Global investors must adhere to regulations of each country.
800-665-0411 - Source - www.Investorideas.com

Tech News Alert: Say Goodbye to Passwords; NXT-ID (OTCQB:NXTD) Patents a Universal Authentication Method to Replace Passwords

SHELTON, CT - March 25, 2014 (Investorideas.com Newswire) NXT-ID, Inc. (OTCQB: NXTD), a biometric authentication company focused on the growing mobile commerce market, announced today that it has submitted a patent application for a universal and adaptable authentication and data exchange method. As a follow-up to U.S. provisional patent application No. 61/802,681, NXT-ID has filed patent application 14/217289 for universal authentication and data exchange method, system and service.

The patent is a significant step forward in NXT-ID's vision to provide its proprietary MobileBio® authentication to a number of applications including financial transactions. MobileBio® enables users to identify themselves to a variety of other devices from a single device carried or worn by an individual.
In the MobileBio® ecosystem, devices know each other from a history of communication between one another. This history builds trust between devices by utilizing another NXT-ID invention, dynamic pairing. Since each device is dynamically paired with one another, it maintains a history of trust to secure its communications. When a user authenticates themselves with a local device such as a phone, watch, ring or a smart wallet, the user is also authenticating with other devices and applications that it encounters. This technology will enable users to seamlessly, securely access devices such as doors, phones, laptops, applications, entertainment systems, even remote services using a single device worn on a person.
"This technology enables users to unlock virtually anything, all from a single device that simply knows who you are," says David Tunnell, CTO of NXT-ID. "This invention supports current authentication methods such as passwords, as well as serves as a bridge to newer forms of authentication such as multi-factor authentication to promote universal security within the internet-of-things. Passwords are never forgotten, kept safe within an electronic vault that can also generate and send strong passwords to automatically login to devices and applications over a variety of communication methods such as Bluetooth and NFC (Near Field Communications)."
"This patent adds to a number of forthcoming technologies that help build our intellectual portfolio in the MobileBio® wearable and mobile markets," says Gino Pereira, CEO of NXT-ID. "We are building products to identify that you are uniquely you. The technology promotes inter-awareness in terms of identity, location, context and utility with secure methods that are dynamic, changing with every new session, and thus difficult to be spoofed."
About NXT- ID Inc. - Mobile Security for a Mobile World
NXT-ID, Inc.'s (OTCQB: NXTD) innovative MobileBio™ solution mitigates consumer risks associated with mobile computing, m-commerce and smart OS-enabled devices. The company is focused on the growing m-commerce market, launching its innovative MobileBio™ suite of biometric solutions that secure consumers' mobile platforms. NXT-ID's wholly owned subsidiary, 3D-ID LLC, is engaged in biometric identification has 22 licensed patents in the field of 3D facial recognition http://www.nxt-id.com/, http://3d-id.net/
Forward-Looking Statements for NXT-ID
This press release contains forward-looking statements as defined within Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Forward-looking statements reflect management's current expectations, as of the date of this press release, and involve certain risks and uncertainties. Forward-looking statements include statements herein with respect to the successful execution of the Company's business strategy. The Company's actual results could differ materially from those anticipated in these forward- looking statements as a result of various factors. Such risks and uncertainties include, among other things, our ability to establish and maintain the proprietary nature of our technology through the patent process, as well as our ability to possibly license from others patents and patent applications necessary to develop products; the availability of financing; the Company's ability to implement its long range business plan for various applications of its technology; the Company's ability to enter into agreements with any necessary marketing and/or distribution partners; the impact of competition, the obtaining and maintenance of any necessary regulatory clearances applicable to applications of the Company's technology; and management of growth and other risks and uncertainties that may be detailed from time to time in the Company's reports filed with the Securities and Exchange Commission.
Contact:
Investor Inquiries:
Kirin Smith
ProActive Capital Group
Direct: 646 863 6519
800 665-0411
Disclaimer/ Disclosure: The Investorideas.com newswire is a third party publisher of news and research as well as creates original content as a news source. Original content created by investorideas is protected by copyright laws other than syndication rights. Investorideas is a news source on Google news and Linkedintoday plus hundreds of syndication partners. Our site does not make recommendations for purchases or sale of stocks or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investment involves risk and possible loss of investment. This site is currently compensated by featured companies, news submissions, content marketing and online advertising. Contact each company directly for press release questions. Disclosure is posted on each release if required but otherwise the news was not compensated for and is published for the sole interest of our readers. Disclosure: November 2013 :Investorideas is compensated by NXTD: five thousand per month for news publication and syndication and is long 144 shares from previous services
More info: http://www.investorideas.com/About/Disclaimer.asp
BC Residents and Investor Disclaimer : Effective September 15 2008 - all BC investors should review all OTC and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar. Read for more info: http://www.bcsc.bc.ca/release.aspx?id=6894. Global investors must adhere to regulations of each country.

Mining Stock Alert: SilverCrest (TSX: SVL) (NYSE MKT: SVLC) Announces 2013 Financial Results Cash Flow from Operations of US$26.1 million ($0.24 per share) Net Earnings US$8.5 million ($0.08 per share)

Vancouver, British Columbia - March 24, 2014 (Investorideas.com Mining Stocks Newswire) SilverCrest Mines Inc. (TSX:SVL) ( NYSE MKT: SVLC) is pleased to announce its audited consolidated financial results for the fourth quarter and year ended December 31, 2013. The fourth quarter and 2013 year end financials results reflect a one-time non-cash deferred tax accounting adjustment of $5.8 million as a result of the enactment of the Mexican Tax Reform. All financial information is prepared in accordance with IFRS and all dollar amounts are expressed in U.S. dollars unless otherwise specified. The information in this news release should be read in conjunction with the Company's audited consolidated financial statements for the year ended December 31, 2013 and associated management discussion and analysis ("MD&A") which are available from the Company's website at www.silvercrestmines.com and under the Company's profile on SEDAR at www.sedar.com.

2013 YEAR END FINANCIAL HIGHLIGHTS :

• Cash flow from operations (1) $26.1 million ($0.24 per share)
• Cash operating cost per silver equivalent ounce sold (2) $7.78 (Ag:Au 60.5:1)
• Revenues reported $54.9 million
• Mine operating earnings $28.9 million
• Deferred tax - Mexican mining royalty $5.8 million (non-cash IFRS accounting entry)
• Net earnings $8.5 million ($0.08 per share)
• Cash and cash equivalents $14.4 million (at Dec. 31, 2013)
• Working capital $25.4 million (at Dec. 31, 2013)
• Scotiabank Credit Facility $40.0 million fully available (at Dec. 31, 2013)

N. Eric Fier, President and COO stated; "2013 was another successful year for SilverCrest, notwithstanding the lower precious metals price environment. The Santa Elena mine delivered strong production and operating cost performance throughout 2013 which allowed SilverCrest to deliver robust financial results. Management are pleased that Santa Elena achieved a cash operating cost of $7.78 per silver equivalent ounce sold compared to Company guidance of $8.50 and an all-in sustaining cash cost per silver equivalent ounce sold (2) of $13.05 which also beat Company guidance of $13.45. SilverCrest maintained its strong balance sheet through disciplined cost management and securing a $40 million credit facility with Scotiabank. SilverCrest will continue to focus on delivering strong operating results and optimizing our operating cash flow as we complete the Santa Elena Expansion and increase production in 2014 to approximately 3.3 million to 3.6 million silver equivalent ounces (Ag:Au 60:1)."
Fourth Quarter ended December 31, 2013
During the fourth quarter, the Company recorded a one-time non-cash deferred tax accounting adjustment of $5.8 million as a result of the enactment of the Mexican Tax Reform. The Company has taken the position that the 7.5% mining royalty is an income tax in accordance with IFRS for financial reporting purpose, as it is based on a measure of revenue less certain specified costs. On substantial enactment, a taxable temporary difference arises, as property, plant and equipment and exploration and evaluation assets have book basis but no tax basis for purposes of the royalty. The Company has recognized a deferred tax liability of $5.8 million as at December 31, 2013 in respect of this royalty. This deferred tax liability will be drawn down to $nil as a reduction to tax expense over the life of mine as the Santa Elena Mine and its related assets are depleted or depreciated.
Net loss was $4,094,410 ($0.04 per share basic) for the fourth quarter compared with net earnings of $13,616,028 ($0.14 per share basic) in 2012. The net loss in the fourth quarter was primarily attributed to lower revenue resulting from significantly lower realized prices and the non‐cash deferred tax accounting adjustment of $5.8 million as a result of the recently enacted Mexican Tax Reform.
Silver and gold revenue totaled $12,866,617, (2012 - $18,243,732) in the fourth quarter. Silver sales were a quarterly record of 208,200 ounces including capitalized underground ounces (2012 - 171,714), 21% higher than the same period in 2012. The foregoing, combined with a 37% lower average realized price at $20 (2012 - $32) per ounce, resulted in 23% less silver revenue. Total gold sales were 8,220 ounces includes capitalized underground ounces (2012 - 8,444) or 3% below 2012. The Company sold 6,576 (2012 - 6,755) ounces of gold at an average realized price of $1,250 (2012 - $1,706) per ounce. The foregoing, 27% decline in realized price, combined with a decline in the ounces of gold sold, resulted in 29% less gold revenue. The Company delivered 1,644 gold ounces (2012 - 1,689) under the Sandstorm Purchase Agreement at $350 per ounce.
Cost of sales amounted to $5,185,211 (2012 - $5,156,489). Cash cost per silver equivalent ounce sold amounted to $7.68, Ag:Au 61.6:1 (2012 - $8.05, Ag:Au 55.6:1). The decrease in cash cost per silver equivalent ounce sold is driven generally by lower mining contractor costs related to a reduction in waste removal. As the Santa Elena Open Pit nears the end of its life, the strip ratio dropped to 1.63:1 in the fourth quarter compared to 3.07:1 for the same period in 2012.
General and administrative expenses increased by 37% to $2,885,989 (2012 - $2,208,355) primarily due to an increase in remuneration and other corporate expenses. Remuneration increased by 37% to $1,581,482 (2012 - $1,158,076) with the addition of new corporate personnel in Q1, 2013, and higher bonuses paid in December to management and employees. Tradeshows and travel increased by 184% to $331,601 (2012 - $116,768) due to an increase in trade show attendance and an accelerated investor relations program. Mexico corporate expenses increased by 47% to $259,488 (2012 - $176,440), with additional tax, legal and corporate activity.
Current income tax expense amounted to $1,580,000, compared to a recovery of $3,494,000 in 2012. For fiscal 2012, the $23.2 million Hedging Facility cash settlement was deductible for Mexican income taxes. Deferred tax expense amounted to $5,420,000 (2012 - $781,000), primarily attributed to a non‐cash accounting adjustment in relation to the Mexican Tax Reform. On December 11, 2013, the Mexican government enacted a tax reform to introduce a mining royalty effective January 2014.
Year ended December 31, 2013
Net earnings were $8,479,263 ($0.08 per share basic) for the year ended December 31, 2013, compared with $30,475,744 ($0.33 per share basic) in 2012. The decrease in net earnings was primarily driven by a decrease in revenue resulting from lower realized prices and lower gold sales combined with higher tax expense recorded compared with 2012 (attributed to the eligible deduction for income tax purposes in 2012 of the Hedging Facility cash settlement and the non‐cash accounting adjustment in 2013 of $5.8 million in relation to the Mexican Tax Reform).
Silver and gold revenue totaled $54,893,651 (2012 - $70,520,085) for fiscal 2013, which includes $53,354,062 (2012 - $63,456,934) received on a cash basis.
SilverCrest sold 751,633 ounces of silver including capitalized underground ounces (2012 - 588,312), 28% higher compared to fiscal 2012. The foregoing, combined with a 27% lower average realized price at $23 (2012 - $32) per ounce, resulted in 7% less silver revenue for the year. SilverCrest sold 30,487 ounces of gold including capitalized underground ounces (2012 - 34,834), 12% lower than fiscal 2012. From this total, the Company sold 24,389 (2012 - 21,383) ounces of gold at an average realized price of $1,392 (2012 - $1,703) per ounce. The foregoing, 18% decline in realized price resulted in 7% less gold revenue than in 2012. The Company delivered 6,097 gold ounces (2012 - 6,967) to Sandstorm at $350 per ounce, and, as the MBL Hedge Facility was settled in 2012, there were no gold deliveries (2012 - 6,484) at $926.50 per ounce.
Cost of sales amounted to $19,895,374 (2012 - $18,307,681). Cash cost per silver equivalent ounce sold amounted to $7.78, Ag:Au 60.5:1 (2012 - $7.39, (Ag:Au 54.3:1), 2013 corporate market guidance estimate was $8.50 per silver equivalent ounce, (Ag:Au 55:1). The increase in 2013 cash cost per silver equivalent ounce sold was driven by higher mining contractor costs, higher processing expenses, and greater general administrative costs from annual salary and benefit increases for mine site personnel.
All-in sustaining cash cost per silver equivalent ounce sold was $13.05, Ag:Au 60.5:1. Company guidance for 2013 was $13.45 per silver equivalent ounce sold.
Current income tax expense amounted to $5,450,000 (2012 - $4,156,000), which relates to the estimate of annual tax payable from Santa Elena operations. The Company has paid a total of $4.7 million related to 2013 income taxes, $3.1 million by offset of Mexican value added taxes receivable, and $1.6 million by offset of 2012 income taxes refund. Deferred tax expense amounted to $7,418,000 (2012 - $1,261,000), primarily attributed to a non ‐ cash accounting adjustment of $5.8 million in relation to the Mexican Tax Reform and recognizing an income tax deduction on 2013 Santa Elena exploration drilling and related costs, which were capitalized for book purposes.
Exchange loss on translation to United States dollars amounted to $1,989,460 (versus an exchange gain of $561,523 in 2012), due to the significant weakening of the Canadian dollar against the United States dollar during fiscal 2013. The financial results of the Company’s Canadian operations were translated at US$1.00 = CAD$0.9949 at December 31, 2012, and US$1.00 = CAD$1.0636 at December 31, 2013.
OUTLOOK FOR 2014
Santa Elena Targets

• Achieve estimated 2014 production guidance of 1.3 million – 1.5 million ounces of silver and 34,000 – 36,000 ounces of gold, for an aggregate of 3.3 million – 3.6 million ounces of silver equivalent, Ag:Au 60:1.
• Achieve estimated cash operating cost of $8.50 - $9.50 per silver equivalent ounce sold, Ag:Au 60:1.
• Complete construction of new conventional 3,000 tpd CCD/MC mill facility in early Q2 2014 - Budget for 2014 is $14 million.
• Complete underground decline development of main ramp to enable physical access to ore starting on level 525m -Budget for 2014 for underground development and equipment purchases is $12 million.

Sonora Project Targets

• Ermitaño Property – initial mapping, sampling and exploration drilling of targets - Budget for 2014 is $550,000.

La Joya Project Targets

• Complete evaluation of certain technical aspects of the project to Pre Feasibility Study level.
• Complete a core drilling program of approximately 20 holes for in-fill drilling of preliminary pit-constrained resources (Preliminary Economic Assessment level) with subsequent metallurgical work. Budget for 2014 is $1 million.
• Complete staged payments of $1.8 million under the La Joya agreements to acquire 100% of the 12 mineral concessions under option.

The Qualified Person under National Instrument (NI 43-101) Standards of Disclosure for Mineral Projects for this News Release is N. Eric Fier, CPG, P.Eng, President and Chief Operating Officer for SilverCrest Mines Inc., who has reviewed and approved its contents.
SilverCrest Mines Inc. (TSX: SVL; NYSE MKT: SVLC)
is a Canadian precious metals producer headquartered in Vancouver, BC. SilverCrest’s flagship property is the 100%-owned Santa Elena Mine, located 150 km northeast of Hermosillo, near Banamichi in the State of Sonora, México. The mine is a high-grade, epithermal silver and gold producer, with an estimated life of mine of 8 years and cash costs of $11 per ounce of silver equivalent (55:1 Ag:Au) for the open pit heap leach and underground mine. SilverCrest anticipates that the new 3,000 tonnes per day conventional mill facility at the Santa Elena Mine should recover an average annual rate of 1.5 million ounces of silver and 32,800 ounces of gold over the current reserve. Major expansion and construction of the 3,000 tonnes per day conventional mill facility is nearing completion and is expected to significantly increase metals production at the Santa Elena Mine (open pit and underground) in 2014 and beyond. Exploration programs continue to make new discoveries at Santa Elena and also have rapidly advanced the definition of a large polymetallic deposit at the La Joya property in Durango State with stated resources nearing 200 million ounces of Ag equivalent.
FORWARD-LOOKING STATEMENTS
This news release contains "forward-looking statements" within the meaning of Canadian securities legislation and the United States Securities Litigation Reform Act of 1995. Such forward-looking statements concern the Company’s anticipated results and developments in the Company’s operations in future periods, planned exploration and development of its properties, plans related to its business and other matters that may occur in the future. These statements relate to analyses and other information that are based on expectations of future performance, including silver and gold production and planned work programs. Statements concerning reserves and mineral resource estimates may also constitute forward-looking statements to the extent that they involve estimates of the mineralization that will be encountered if the property is developed and, in the case of mineral reserves, such statements reflect the conclusion based on certain assumptions that the mineral deposit can be economically exploited.
Forward-looking statements are subject to a variety of known and unknown risks, uncertainties and other factors which could cause actual events or results to differ from those expressed or implied by the forward-looking statements, including, without limitation: risks related to precious and base metal price fluctuations; risks related to fluctuations in the currency markets (particularly the Mexican peso, Canadian dollar and United States dollar); risks related to the inherently dangerous activity of mining, including conditions or events beyond our control, and operating or technical difficulties in mineral exploration, development and mining activities; uncertainty in the Company’s ability to raise financing and fund the exploration and development of its mineral properties; uncertainty as to actual capital costs, operating costs, production and economic returns, and uncertainty that development activities will result in profitable mining operations; risks related to reserves and mineral resource figures being estimates based on interpretations and assumptions which may result in less mineral production under actual conditions than is currently estimated and to diminishing quantities or grades of mineral reserves as properties are mined; risks related to governmental regulations and obtaining necessary licenses and permits; risks related to the business being subject to environmental laws and regulations which may increase costs of doing business and restrict our operations; risks related to mineral properties being subject to prior unregistered agreements, transfers, or claims and other defects in title; risks relating to inadequate insurance or inability to obtain insurance; risks related to potential litigation; risks related to the global economy; risks related to the Company’s status as a foreign private issuer in the United States; risks related to all of the Company’s properties being located in Mexico and El Salvador, including political, economic, social and regulatory instability; and risks related to officers and directors becoming associated with other natural resource companies which may give rise to conflicts of interests. Should one or more of these risks and uncertainties materialize, or should underlying assumptions prove incorrect, actual results may vary materially from those described in the forward-looking statements. The Company’s forward-looking statements are based on beliefs, expectations and opinions of management on the date the statements are made. For the reasons set forth above, investors should not place undue reliance on forward-looking statements.
The information provided in this news release is not intended to be a comprehensive review of all matters and developments concerning the Company. It should be read in conjunction with all other disclosure documents of the Company. The information contained herein is not a substitute for detailed investigation or analysis. No securities commission or regulatory authority has reviewed the accuracy or adequacy of the information presented.
Contact:
Fred Cooper (Investor Relations)
J. Scott Drever (CEO)
Telephone: (604) 694-1730
Fax: (604) 694-1761
Toll Free: 1-866-691-1730
Email: info@silvercrestmines.com
Website: www.silvercrestmines.com
Address: Suite 501 - 570 Granville Street
Vancouver, BC Canada V6C 3P1
Published at Investorideas.com Newswire
Disclaimer / Disclosure : The Investorideas.com is a third party publisher of news and research Our sites do not make recommendations, but offer information portals to research news, articles, stock lists and recent research. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. This site is currently compensated by featured companies, news submissions and online advertising. Disclosure: SilverCrest Mines has compensated Investorideas.com for the distribution and publishing of this news release (annual news publication 9700) http://www.investorideas.com/About/Disclaimer.asp
BC Residents and Investor Disclaimer : Effective September 15 2008 - all BC investors should review all OTC and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar. Read for more info: http://www.bcsc.bc.ca/release.aspx?id=6894

Authentication/ Cybersecurity Breaking News: NXT-ID, Inc. (OTCQB: NXTD) Patents the "Un-Password"

SHELTON, CT - March 20, 2014 (Investorideas.com Newswire) NXT-ID, Inc. (OTCQB: NXTD), a biometric authentication company focused on the growing mobile commerce market, announced today that it has submitted a patent application for dynamic pairing. As a follow up to U.S. provisional patent application No. 61/802,681, NXT-ID has filed patent application 14/049175 for

THE "UN-PASSWORD™: RISK AWARE END-TO-END MULTI-FACTOR AUTHENTICATION VIA DYNAMIC PAIRING.
This patent represents advancements in biometric and cryptographic authentication, and another key technology to NXT-ID's widely anticipated next generation payment and identity product -- the Wocket™.
Dynamic pairing addresses several vulnerabilities facing current authentication methods. These include "brute force" attacks, where attacking computers systematically check all possible passwords until one is found, and "man in the middle" attacks, which caused the Target and other recent retail data breaches where the attacker impersonates each end point to the satisfaction of the other.
"We wanted to develop a method where devices could establish trust with one another, but without exposing any private information that could be used in an attack or identity theft," says David Tunnell, CTO of NXT-ID. "Instead of passing private, identifiable information about an individual over the internet, we send dynamic pairing codes that contain hidden risk assessments. Each new risk assessment measures how sure 'you are who you say you are' based on multi-factor authentication such as biometrics. Since each new risk assessment is dynamic and hidden within the dynamic pairing code, it makes cyber attacks extremely difficult and easy to detect, while enabling authentication and encryption across remote devices and services."
Dynamic pairing is flexible, easy to implement, and brings a high level of trust to transactions without sharing any private information that could be used for cyber attack. With dynamic pairing, private data is kept private, under the control of the owner of the data where it belongs so that your identity cannot be stolen, while still enabling other systems to trust the authenticity of a user, device or application.
"We believe dynamic pairing could change the way access is given in a vast number of applications and help to prevent substantial losses in the financial payments industry," says Gino Pereira, CEO of NXT-ID. "Dynamic pairing can make a significant difference in identity management and secure communications while enabling individuals to keep their critical and private information from being stolen. Our first application of this innovative technology of course will be our Wocket™ Smart Wallet."
Wocket™ is a new biometrically secure smart wallet designed to replace the traditional wallet and the number of cards consumers carry. Its dynamically programmable magnetic stripe, NXTCard can replace up to 20,000 cards and can include medical records, ID, coupons etc. that are currently kept in a wallet, with one single secure card. Wocket will feature interchangeable accessories, which are direct attachments, to offer various styles, textures and colors to support a variety of common uses including carrying cash. Wocket™ is a smart wallet that can completely replace your existing wallet with more functionality, comfort, style and security.
About NXT- ID Inc. - Mobile Security for a Mobile World
NXT-ID, Inc.'s (OTCQB: NXTD) innovative MobileBio™ solution mitigates consumer risks associated with mobile computing, m-commerce and smart OS-enabled devices. The company is focused on the growing m-commerce market, launching its innovative MobileBio™ suite of biometric solutions that secure consumers' mobile platforms led by the Wocket™; a next generation smart wallet designed to replace all the cards in your wallet, no smart phone required. The Wocket works anywhere credit cards are accepted and only works with your biometric stamp of approval. http://www.thewocket.com/
NXT-ID' wholly owned subsidiary, 3D-ID LLC, is engaged in biometric identification has 22 licensed patents in the field of 3D facial recognition http://www.nxt-id.com/, http://3d-id.net/
Forward-Looking Statements for NXT-ID
This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements reflect management's current expectations, as of the date of this press release, and involve certain risks and uncertainties. Forward-looking statements include statements herein with respect to the successful execution of the Company's business strategy. The Company's actual results could differ materially from those anticipated in these forward-looking statements as a result of various factors. Such risks and uncertainties include, among other things, our ability to establish and maintain the proprietary nature of our technology through the patent process, as well as our ability to possibly license from others patents and patent applications necessary to develop products; the availability of financing; the Company's ability to implement its long range business plan for various applications of its technology; the Company's ability to enter into agreements with any necessary marketing and/or distribution partners; the impact of competition, the obtaining and maintenance of any necessary regulatory clearances applicable to applications of the Company's technology; and management of growth and other risks and uncertainties that may be detailed from time to time in the Company's reports filed with the Securities and Exchange Commission.
Contact:
Investor Inquiries:
Kirin Smith
ProActive Capital Group
Direct: 646 863 6519
800 665-0411
Disclaimer/ Disclosure: The Investorideas.com newswire is a third party publisher of news and research as well as creates original content as a news source. Original content created by investorideas is protected by copyright laws other than syndication rights. Investorideas is a news source on Google news and Linkedintoday plus hundreds of syndication partners. Our site does not make recommendations for purchases or sale of stocks or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investment involves risk and possible loss of investment. This site is currently compensated by featured companies, news submissions, content marketing and online advertising. Contact each company directly for press release questions. Disclosure is posted on each release if required but otherwise the news was not compensated for and is published for the sole interest of our readers. Disclosure: November 2013 :Investorideas is compensated by NXTD: five thousand per month for news publication and syndication and is long 144 shares from previous services
More info: http://www.investorideas.com/About/Disclaimer.asp
BC Residents and Investor Disclaimer : Effective September 15 2008 - all BC investors should review all OTC and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar. Read for more info: http://www.bcsc.bc.ca/release.aspx?id=6894. Global investors must adhere to regulations of each country.

Medical Technology Breaking News: Aethlon Medical (OTCQB: AEMD) and Exosome Sciences Expand Brain Research Discoveries to Include Isolation of Glioblastoma Biomarker and Therapeutic Target

SAN DIEGO - March 19, 2014 (Investorideas.com newswire) Aethlon Medical, Inc. (OTCBB:AEMD), and its diagnostic subsidiary, Exosome Sciences, Inc. (ESI), announced today that researchers have isolated brainderived exosomes released into the bloodstream from aggressive brain tumors. Through the use of proprietary size exclusion/lectin/antibody-capture techniques, the Aethlon-ESI research team was able to identify, quantify, and characterize circulating Glioblastoma multiforme (GBM) exosomes, which hold promise as both a disease biomarker and therapeutic target as GBM exosomes are shed into the circulatory system to promote tumor growth and stimulate angiogenesis.

"Building on our proprietary method to identify, quantitate and characterize brain-derived exosomes, we now have the ability to detect this aggressive cancer early and aid in its treatment," stated ESI Chief Scientific Officer, Dr. Douglas Taylor.
Aethlon Medical develops therapeutic filtration devices to address infectious disease, cancer and other life-threatening conditions. The Aethlon Hemopurifier® is a first in class medical device that addresses a broad-spectrum of viral pathogens as well as tumor-secreted exosomes that promote cancer progression and suppress the immune system of cancer patients. Aethlon is currently preparing to launch the first FDA approved clinical study of Hemopurifier® therapy in the United States. ESI was established by Aethlon to develop non-invasive exosome-based "liquid biopsies" that diagnose and monitor acute and chronic disease conditions.
GBM represents the most common, per capita costly and uniformly lethal primary brain tumor. GBM comprise 23% of primary brain tumors in the US and is the most commonly diagnosed brain tumor in adults aged 45-74 with men being more frequently diagnosed than women. The prognosis remains poor despite aggressive treatment modalities. Over the past decade, a median survival time of 12 months has only been marginally improved to 14.6 months as a result of advances in chemo/radiation and the use of molecularly targeted agents. Beyond being a candidate target for Hemopurifier® therapy, the discovery of circulating GBM-exosomes offers a potential new paradigm in GBM clinical management through a platform technology to predict tumor regression or progression.
"The ability to characterize disease specific exosomes in circulation will enable improved diagnosis to identify type and grade of these most challenging of brain tumors and may additionally help to advance novel treatment strategies," stated Dr. Cicek Gercel-Taylor, Clinical Research Director at ESI.
To date, there have been two critical barriers to successful GBM treatment. First, there currently is no method for evaluating the dynamic changes in GBM during therapy. Standard imaging approaches do not provide metrics of tumor-specific genetic/phenotypic changes and operative information is expensive, potentially morbid and limited by errors in topographic sampling. Second, clinicians, lacking tumor-specific parameters, are unable to effectively monitor responses to therapy over short time frames. These limitations are derived from the difficulty in obtaining repeated biopsies of tumor tissue, and the confounding effects on tumor MRI of necrosis, inflammation, surgical artifact and edema. Additionally, the appearance of GBM by current imaging techniques is not specific, since other lesions such as abscess, metastasis, and other entities may have a similar appearance. As a result, clinicians have not been able to adequately evaluate therapeutic agents designed to target GBM. The objective of the Aethlon-ESI team is to extend and improve GBM patient quality of life by resolving the clinical challenges of monitoring patient response to both established and candidate therapies.
Earlier this month, the Aethlon-ESI research team disclosed that it was also to isolate brain-specific biomarkers that could have implications in the diagnosis, monitoring and treatment of Alzheimer’s Disease (AD), Chronic Traumatic Encephalopathy (CTE) and Traumatic Brain Injury (TBI). The research studies provided evidence that exosomes can serve as a "liquid biopsy" to diagnose neurologic conditions. While exosomes from the central nervous system have previously been identified in the cerebrospinal fluid, the Aethlon-ESI study identified exosomes carrying brain-specific markers tau, beta-amyloid, glycoprotein A2B5 and S100B protein in the peripheral circulation of affected individuals. The discoveries provide a basis for an exosome-based platform that could enable the simultaneous identification of multiple brain specific markers that are transported across the blood-brain barrier and into the circulatory system.
CTE is a progressive degenerative disease, which at present can only be definitively diagnosed postmortem. CTE has been most commonly found at autopsy in former professional football players and has also been demonstrated to be prevalent in soldiers exposed to blast injury. The hallmark of CTE is the accumulation of tau, an abnormal protein that strangles brains cells in areas that control memory, emotions and other functions. TBI or repetitive brain trauma, including concussions and sub-concussive blows to the head contribute to the onset of CTE.
AD is the most common form of dementia. There is no cure for the disease, which worsens as it progresses, and eventually leads to death. Beta-amyloid plaques and neurofibrillary tangles have long been recognized as a common pathologic hallmark of AD. In 2010, it was estimated that 36 million people worldwide were living with AD.
About Aethlon Medical, Inc.
Aethlon Medical creates innovative medical devices to address life-threatening diseases. The Aethlon ADAPT™ (Adaptive Dialysis-like Affinity Platform Technology) establishes the basis for a new class of therapeutics that target the rapid elimination of disease enabling particles from the circulatory system of treated patients. The lead Aethlon ADAPT™ product is the Hemopurifier®, a device that addresses a broad-spectrum of viral pathogens as well as tumorsecreted exosomes that suppress the immune system of cancer patients. Aethlon is also operating under two government contracts with the Defense Advanced Research Projects Agency (DARPA) related the development of a medical device to reduce the incidence of sepsis. Exosome Sciences, Inc. is a majority owned Aethlon subsidiary that is advancing exosome-based strategies to diagnose and monitor cancer and infectious disease progression. Additional information can be found at www.AethlonMedical.com
About Exosome Sciences, Inc.
Exosome Sciences (ESI), a majority wholly owned subsidiary of Aethlon Medical, Inc., develops exosome-based solutions to improve identification and monitoring of acute and chronic conditions. Our candidate products are focused toward diagnostic advancements in the fields of oncology, infectious disease and brain injury. Exosomes represent an optimal diagnostic target as diseased or injured cells release these particles into body fluids such as urine, blood, saliva and cerebrospinal fluid where they can be accessed for analysis. Our exosome-based assays unlock the ability to identify proteomic and genomic alterations underlying a wide-range of pathologies, thus allowing for the introduction of novel non-invasive "liquid biopsies". Additional information can be found at www.ExosomeSciences.com.
Certain statements herein may be forward-looking and involve risks and uncertainties. Such forward-looking statements involve assumptions, known and unknown risks, uncertainties and other factors which may cause the actual results, performance or achievements of Aethlon Medical, Inc. to be materially different from any future results, performance, or achievements expressed or implied by the forward-looking statements. Such potential risks and uncertainties include, without limitation, that the ESI will not be able to commercialize its future products, that the FDA will not approve the initiation of the Company's existing or future clinical programs or provide market clearance of the company's products, future human studies whether revenue or non-revenue generating of the Aethlon ADAPT™ system or the Aethlon Hemopurifier® as an adjunct therapy to improve patient responsiveness to established cancer or hepatitis C therapies or as a standalone cancer or hepatitis C therapy, the Company's ability to raise capital when needed, the Company's ability to complete the development of its planned products, the Company's ability to manufacture its products either internally or through outside companies and provide its services, the impact of government regulations, patent protection on the Company's proprietary technology, the ability of the Company to meet the milestones contemplated in the DARPA contract, product liability exposure, uncertainty of market acceptance, competition, technological change, and other risk factors. In such instances, actual results could differ materially as a result of a variety of factors, including the risks associated with the effect of changing economic conditions and other risk factors detailed in the Company's Securities and Exchange Commission filings. The Company undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events, or otherwise.
Contacts:
James A. Joyce
Chairman and CEO
858.459.7800 x301
jj@aethlonmedical.com
Jim Frakes
Chief Financial Officer
858.459.7800 x300
jfrakes@aethlonmedical.com
Marc Robins
877.276.2467
mr@aethlonmedical.com
Published at Investorideas.com newswire
Sign up for the free investor news and stock alerts
http://www.investorideas.com/Resources/Newsletter.asp
Disclaimer / Disclosure: The Investorideas.com is a third party publisher of news and research Our sites do not make recommendations, but offer information portals to research news, articles, stock lists and recent research. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. Disclosure: Investorideas has been compensated by AEMD for news distribution and content publishing: 2425 quarterly for annual news publishing only starting Feb 26th 2014
http://www.investorideas.com/About/Disclaimer.asp
This site is currently compensated by featured companies, news submissions and online advertising.
BC Residents and Investor Disclaimer : Effective September 15 2008 - all BC investors should review all OTC and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar

Video Release for Investorideas.com Security Conference: Hear Experts in Biometrics, Cybersecurity, Drones, Biodefense

New York, NY - March 17, 2014 (www.investorideas.com newswire) Investorideas.com, an investor research and news portal covering leading sectors including technology and defense announces the full video release for the Security and Defense Conference, "Game Changing Technologies: The Face and Future of Security", held both live in New York and online on March 11, 2014.

Full Speaker Bios, Presenting Companies and Conference info:
http://www.investorideas.com/Conference/
Video Clips:
What is the Key to Staying Ahead?
MICHAEL BALBONI, Former New York State Senator; Founder RedLand Strategies, Inc.
VIDEO LINK: https://www.youtube.com/watch?v=grwrV5F7flg
Welcome & Opening Remarks
SPEAKER: RICHARD KENDALL, Federal Enforcement Homeland Security Foundation
VIDEO LINK: https://www.youtube.com/watch?v=Iu_hC_eZxy8
Game Changing Technologies: The Face and Future of Security;
MODERATOR: ROGER CRESSEY, Liberty Group Ventures
PANELISTS: SCOTT GREIPER, Secure Strategy Group; MARTY MARTIN, Crane & Crane Consulting; JANICE KEPHART, The Secure Identity and Biometrics Association (SIBA)
VIDEO LINK: https://www.youtube.com/watch?v=shXCEWuo9oY
Applied DNA Sciences, Inc. (APDN)
VIDEO LINK: https://www.youtube.com/watch?v=jGAt0zTFG54
Viscount Systems (OTCQB: VSYS)
VIDEO LINK: https://www.youtube.com/watch?v=QjjLOFaQMAA
American Public University System (NASDAQ: APEI)
VIDEO LINK: https://www.youtube.com/watch?v=0ng-ibM6Shc
NXT-ID (OTCQB: NXTD)
VIDEO LINK: https://www.youtube.com/watch?v=PdWiAF5Wuto
Exploring the NIST Cybersecurity Framework and Implementation
SPEAKERS: KIERSTEN TODT & ROGER CRESSEY, Liberty Group Ventures
VIDEO LINK: https://www.youtube.com/watch?v=seRpNxXLoSU
Performance and Investing opportunities in Security and Defense Companies
MODERATOR: SCOTT GREIPER, Secure Strategy Group
PANELISTS: SCOTT SACKNOFF, SPADE Indexes; KRIS TUTTLE, Soundview Technology Group; MANISH THAKUR, Hudson Fairfax Group; PHIL AGCAOLI, Cloud Security Alliance
VIDEO LINK: https://www.youtube.com/watch?v=pVZKWHNEBeY
Tekcapital, Ltd.
VIDEO LINK: https://www.youtube.com/watch?v=ofpD5MZQF6w
PositiveID Corporation (OTCBB: PSID)
VIDEO LINK: https://www.youtube.com/watch?v=9hez8sZ7bXU
Implant Sciences (OTCQB: IMSC)
VIDEO LINK: https://www.youtube.com/watch?v=h3J_EVqmZyA
Silanis Technology
VIDEO LINK: https://www.youtube.com/watch?v=I2SLTv02vnQ
Closing Remarks
SPEAKER: LESTER QUINTANA, Cellucci Associates, Inc.
More: http://www.investorideas.com/Conference/Speakers-More-Info.asp

• This video is not available

The conference was free to attend but donations are welcomed to Federal Enforcement Homeland Security Foundation. The Federal Enforcement Homeland Security Foundation is a Non-Profit 501 c (3) Corporation formed to assist the Federal Law Enforcement Community (ATF, CBP, DEA, FAMS, FBI, ICE, Secret Service, U S Marshal's) and their families in times of need especially related to Line of Duty deaths along with health or medical issues involving family members. Our Country needs these courageous men and women who wear the uniform in our ongoing fight against domestic and international terrorism and in the general enforcement of our Country's Laws.
www.fehsf.org
About InvestorIdeas.com: www.investorideas.com
InvestorIdeas.com is a global news source for investors following leading business sectors including biotech, tech, mining, mobile, energy, water, defense and security, renewable energy, food and beverage stocks and Latin American stocks.
Disclaimer/ Disclosure: The Investorideas.com newswire is a third party publisher of news and research as well as creates original content as a news source. Original content created by investorideas is protected by copyright laws other than syndication rights. Investorideas is a news source on Google news and Linkedintoday plus hundreds of syndication partners. Our site does not make recommendations for purchases or sale of stocks or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investment involves risk and possible loss of investment. This site is currently compensated by featured companies, news submissions, content marketing and online advertising. Contact each company directly for press release questions. Disclosure is posted on each release if required but otherwise the news was not compensated for and is published for the sole interest of our readers. More disclaimer info: http://www.investorideas.com/About/Disclaimer.asp BC Residents and Investor Disclaimer : Effective September 15 2008 - all BC investors should review all OTC and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar. Read for more info: http://www.bcsc.bc.ca/release.aspx?id=6894 . Global investors must adhere to regulations of each country
800-665-0411 - Source: www.Investorideas.com

Full Video Release for Investorideas.com Security Conference: Cybersecurity, Biometrics, Biodefense, Explosive Detection, Drones Discussed by Industry and Financial Experts, Publicly Traded and Private Companies

New York, NY - March 14, 2014 (www.investorideas.com newswire) Investorideas.com, an investor research and news portal covering leading sectors including technology and defense announces the full video release for the Security and Defense Conference, "Game Changing Technologies: The Face and Future of Security", held both live in New York and online on March 11, 2014.

When /where:
Tuesday, March 11, 2014, The New York Hilton Midtown, New York City (1335 Avenue of the Americas, New York, NY 10019) and Online
Conference info: http://www.investorideas.com/Conference/
What is the Key to Staying Ahead?
Featured Speaker: MICHAEL BALBONI, Former New York State Senator; Founder RedLand Strategies, Inc.
Welcome & Opening Remarks
SPEAKER: RICHARD KENDALL, Federal Enforcement Homeland Security Foundation
Game Changing Technologies: The Face and Future of Security;
The technology of authentication, biometrics, biodefense, cyber security, drones, nanotechnology and unmanned aerial vehicles (UAV) is evolving faster than we think. This panel of industry experts discusses the current state of the security and defense industry, and explores where it's headed in 2014 and beyond.
MODERATOR: ROGER CRESSEY, Liberty Group Ventures
PANELISTS: SCOTT GREIPER, Secure Strategy Group; MARTY MARTIN, Crane & Crane Consulting; JANICE KEPHART, The Secure Identity and Biometrics Association (SIBA)
Applied DNA Sciences, Inc. (APDN)
Viscount Systems (OTCQB: VSYS)
American Public University System (NASDAQ: APEI)
NXT-ID (OTCQB: NXTD)
Exploring the NIST Cybersecurity Framework and Implementation
Under Executive Order, President Obama directed The National Institute of Standards and Technology (NIST) to "work with stakeholders to develop a voluntary framework for reducing cyber risks to critical infrastructure." Kiersten Todt and Roger Cressey supported the NIST in drafting the Cybersecurity framework and soliciting input from the private sector. This session explores the framework, its implementation in key critical infrastructure sectors, and the impact of these cybersecurity policies on the industry and emerging businesses. SPEAKERS: KIERSTEN TODT & ROGER CRESSEY, Liberty Group Ventures
Performance and Investing opportunities in Security and Defense Companies
This panel of financial experts examines recent trends on the financial landscape of the industry, the performance of various investment opportunities in the sector, and how to position your company properly for investment and growth.
MODERATOR: SCOTT GREIPER, Secure Strategy Group
PANELISTS: SCOTT SACKNOFF, SPADE Indexes; KRIS TUTTLE, Soundview Technology Group; MANISH THAKUR, Hudson Fairfax Group; PHIL AGCAOLI, Cloud Security Alliance
Tekcapital, Ltd.
PositiveID Corporation (OTCBB: PSID)
Implant Sciences (OTCQB: IMSC)
Silanis Technology
Closing Remarks
SPEAKER: LESTER QUINTANA, Cellucci Associates, Inc.
Mr. Quintana is a dynamic high-technology Business Executive with a strategic business and tactical operations background; he has held key positions in the Department of Defense, Department of Homeland Security, and other agencies. He has been engaged in Russia, States of the Former Soviet Union, Kuwait, Iraq, and globally sensitive locations.
More: http://www.investorideas.com/Conference/Speakers-More-Info.asp
The conference was free to attend but donations are welcomed to Federal Enforcement Homeland Security Foundation. The Federal Enforcement Homeland Security Foundation is a Non-Profit 501 c (3) Corporation formed to assist the Federal Law Enforcement Community (ATF, CBP, DEA, FAMS, FBI, ICE, Secret Service, U S Marshal's) and their families in times of need especially related to Line of Duty deaths along with health or medical issues involving family members. Our Country needs these courageous men and women who wear the uniform in our ongoing fight against domestic and international terrorism and in the general enforcement of our Country's Laws. www.fehsf.org
Media Partners:
Media partners include www.SecuritySolutionsWatch.com, a breaking news site covering new security solutions and business trends; SecurityStockWatch.com for investors following the sector; www.Wallstreetcalendar.com , informing the institutional investment community; Australian Security Magazine ( http://www.australiansecuritymagazine.com.au/ ); Global Security Finance ( www.globalsecurityfinance.com ), an online daily news and data service covering the physical, cyber and identity security and defense sectors; Hedge Connection ( https://www.hedgeconnection.com ), an interactive, web-based marketing tool available to hedge funds and investors; www.biometricupdate.com and http://www.biometricstechnologywatch.com/.
About InvestorIdeas.com: www.investorideas.com
InvestorIdeas.com is a global news source for investors following leading business sectors including biotech, tech, mining, mobile, energy, water, defense and security, renewable energy, food and beverage stocks and Latin American stocks.
Disclaimer/ Disclosure: The Investorideas.com newswire is a third party publisher of news and research as well as creates original content as a news source. Original content created by investorideas is protected by copyright laws other than syndication rights. Investorideas is a news source on Google news and Linkedintoday plus hundreds of syndication partners. Our site does not make recommendations for purchases or sale of stocks or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investment involves risk and possible loss of investment. This site is currently compensated by featured companies, news submissions, content marketing and online advertising. Contact each company directly for press release questions. Disclosure is posted on each release if required but otherwise the news was not compensated for and is published for the sole interest of our readers. More disclaimer info: http://www.investorideas.com/About/Disclaimer.asp BC Residents and Investor Disclaimer : Effective September 15 2008 - all BC investors should review all OTC and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar. Read for more info: http://www.bcsc.bc.ca/release.aspx?id=6894 . Global investors must adhere to regulations of each country
Presenting Companies Contact info:
Cali Van Zant cvanzant@investorideas.com 800. 665. 0411
Sponsorship info:
Eric Salvarezza esalvarezza@investorideas.com 631. 664. 1311
Media Partners: D. Van Zant dvanzant@investorideas.com 800. 665. 0411
800-665-0411 - Source: www.Investorideas.com
Become an Investorideas.com Member and access our 14 online stock directories 24/7 - defense stocks, technology stocks, mining stocks, oil and gas stocks and more... http://www.investorideas.com/membership/

TSX Mining News: GARIBALDI (TSX.V:GGI) BROADENS MINERALIZED CORRIDOR AT GRIZZLY, PREPARES TO ACCELERATE 2014 EXPLORATION PLANS

Vancouver, British Columbia - March 14, 2014 (Investorideas.com Mining stocks newswire) Garibaldi Resources Corp. (TSX.V: GGI; OTC: GGIFF; Frankfurt: RQM) (the "Company" or "Garibaldi") is pleased to report that recent reconnaissance work carried out over western portions of its Grizzly Property in the Sheslay Valley, northwest British Columbia, has identified a new zone of porphyry copper mineralization 3 km south of its Grizzly West porphyry target and 3 km west-southwest of Prosper Gold Corp.'s Pyrrhotite Creek prospect in an area referred to as West Kaketsa. Garibaldi is the largest landholder among juniors in the Sheslay district and controls approximately 26,200 hectares in claims. The results of this program suggests potential to significantly broaden a NW/SE trending corridor of porphyry targets that extends for over 30 km through the Sheslay Valley from the western end of the Grizzly Property through Grizzly Central to the recently announced Grizzly East expansion claims.

Given highly encouraging results in the western and central parts of the Grizzly Property, Garibaldi is accelerating its 2014 plans at the Grizzly by launching an aggressive Phase 1 exploration program to include detailed mapping, geochemistry, IP surveys and drilling. The initial stages of this work will commence in the next few weeks and the results will determine the scale of a planned Phase 2 program. Garibaldi is in a strong working capital position and is looking forward to advancing the Grizzly Project concurrently with its assets in Mexico.
"The importance of the discoveries recently announced by Prosper Gold and Doubleview Capital Corp., located approximately 10 km apart on properties within the Sheslay corridor, is the scale of mineralization over such wide distances. Confirmation of another significant porphyry target area several km south of Grizzly West underscores the world class potential of this growing mineralized Cu-Au porphyry corridor in the Sheslay Valley," explained Steve Regoci, Garibaldi President and CEO. "Garibaldi has captured more than 50% of this very prospective corridor with multiple targets already identified from Grizzly West to Grizzly Central through geophysical and geochemical surveys. We're very excited about advancing the Grizzly to a first-ever drilling stage."
West Kaketsa Mineralization Similar To Grizzly West, Pyrrhotite Creek
The extent of the newly discovered mineralized area at West Kaketsa is yet to be determined but it's located approximately 1 km north of the historic West Kaketsa prospect (B.C. Minfile # 104J-024) and appears to be related to a fault that extends at least 3 km to Pyrrhotite Creek on the eastern flank of Mount Kaketsa. Garibaldi's upcoming program at the Grizzly Property includes plans to further define this new zone with IP surveys and identify potential drill targets.
Petrographic analysis of mineralization from both the West Kaketsa and Grizzly West prospects has confirmed that both areas exhibit classic porphyry-style copper-gold mineralization including hydraulic brecciation, disseminated chalcopyrite and intense alteration within a hydrothermal environment. Garibaldi's reconnaissance work identified the new mineralized zone while following up on an encouraging airborne magnetic and radiometric survey completed last fall over western portions of the Grizzly Property.
The airborne survey confirmed that West Kaketsa, like Grizzly West, is in a region of strong magnetic activity and structure, the latter indicating faults and fractures in the intrusive bodies favorable for mineralizing fluids along the contact zones of the Mount Kaketsa monzonite granodiorite stock. Historic technical reports describe porphyry mineralization at West Kaketsa as being similar to mineralization observed at Pyrrhotite Creek. Prosper Gold has reported that Pyrrhotite Creek is a large mineralized zone with multiple porphyry targets located 3 km southwest of the Star porphyries in the SW corner of its Sheslay Property adjoining the Grizzly.
Grizzly West
Last fall's airborne survey shows that Grizzly West is on the periphery of a large magnetic anomaly, in a similar setting to targets on the adjoining Sheslay Property. A soil geochemical survey has defined several strong copper anomalies open in multiple directions at Grizzly West with the grid covering an area approximately 1.5 km x 1.5 km. Fieldwork at this target has confirmed historical reports (Corona Resources) of mineralization with reported grades ranging from 0.20% Cu to 6.7% Cu in rock chip samples.
Maps – West Kaketsa & Grizzly West
Maps showing location, sampling areas and full results from recent work completed at West Kaketsa and Grizzly West are available on the Garibaldi web site at www.GaribaldiResources.com.
To view a 2.5-minute video on the Grizzly Property and the Sheslay Valley, please visit the following URL: http://www.garibaldiresources.com/s/Media.asp#video1
Qualified Person
Carl von Einsiedel, P.Geo., a non-independent geological consultant and a Qualified Person as defined by NI-43-101 has reviewed this release and approved the content thereof.
About Garibaldi
Garibaldi Resources Corp. is an active Canadian-based junior exploration company focused on creating shareholder value through discoveries and strategic development of its assets in some of the most prolific mining regions of Mexico and British Columbia.
We seek safe harbor.
GARIBALDI RESOURCES CORP.
Steve Regoci, President & CEO

Mining Stock Alert: SilverCrest (TSX: SVL) (NYSE MKT: SVLC) Closes $23,023,000 Prospectus Offering, Over-Allotment Option Exercised in Full

Vancouver, British Columbia - March 13, 2014 (Investorideas.com Mining Stocks Newswire) SilverCrest Mines Inc. (TSX:SVL) ( NYSE MKT: SVLC) is pleased to announce the completion of its prospectus offering announced on February 19, 2014 whereby the Company issued a total of 8,855,000 common shares at a price of $2.60 per common share for gross proceeds of $23,023,000, including exercise of the over-allotment option in full. The offering was led by Dundee Securities Ltd., and included National Bank Financial Inc., Raymond James Ltd. and PI Financial Corp. as underwriters.

The Company plans to use the net proceeds of the offering for working capital and general corporate purposes.
The securities described herein have not been and will not be registered under the United States Securities Act of 1933, as amended, or the securities laws of any state and may not be offered or sold in the United States absent an exemption from registration.
SilverCrest Mines Inc. (TSX: SVL; NYSE MKT: SVLC)
is a Canadian precious metals producer headquartered in Vancouver, BC. SilverCrest’s flagship property is the 100%-owned Santa Elena Mine, located 150 km northeast of Hermosillo, near Banamichi in the State of Sonora, México. The mine is a high-grade, epithermal silver and gold producer, with an estimated life of mine of 8 years and cash costs of $11 per ounce of silver equivalent (55:1 Ag:Au) for the open pit heap leach and underground mine. SilverCrest anticipates that the new 3,000 tonnes per day conventional mill facility at the Santa Elena Mine should recover an average annual rate of 1.5 million ounces of silver and 32,800 ounces of gold over the current reserve. Major expansion and construction of the 3,000 tonnes per day conventional mill facility is nearing completion and is expected to significantly increase metals production at the Santa Elena Mine (open pit and underground) in 2014 and beyond. Exploration programs continue to make new discoveries at Santa Elena and also have rapidly advanced the definition of a large polymetallic deposit at the La Joya property in Durango State with stated resources nearing 200 million ounces of Ag equivalent.
FORWARD-LOOKING STATEMENTS
This news release contains “forward-looking statements” within the meaning of Canadian securities legislation and the United States Securities Litigation Reform Act of 1995. Such forward-looking statements concern the Company’s anticipated results and developments in the Company’s operations in future periods, planned exploration and development of its properties, plans related to its business and other matters that may occur in the future. These statements relate to analyses and other information that are based on expectations of future performance, including silver and gold production and planned work programs. Statements concerning reserves and mineral resource estimates may also constitute forward-looking statements to the extent that they involve estimates of the mineralization that will be encountered if the property is developed and, in the case of mineral reserves, such statements reflect the conclusion based on certain assumptions that the mineral deposit can be economically exploited.
Forward-looking statements are subject to a variety of known and unknown risks, uncertainties and other factors which could cause actual events or results to differ from those expressed or implied by the forward-looking statements, including, without limitation: risks related to precious and base metal price fluctuations; risks related to fluctuations in the currency markets (particularly the Mexican peso, Canadian dollar and United States dollar); risks related to the inherently dangerous activity of mining, including conditions or events beyond our control, and operating or technical difficulties in mineral exploration, development and mining activities; uncertainty in the Company’s ability to raise financing and fund the exploration and development of its mineral properties; uncertainty as to actual capital costs, operating costs, production and economic returns, and uncertainty that development activities will result in profitable mining operations; risks related to reserves and mineral resource figures being estimates based on interpretations and assumptions which may result in less mineral production under actual conditions than is currently estimated and to diminishing quantities or grades of mineral reserves as properties are mined; risks related to governmental regulations and obtaining necessary licenses and permits; risks related to the business being subject to environmental laws and regulations which may increase costs of doing business and restrict our operations; risks related to mineral properties being subject to prior unregistered agreements, transfers, or claims and other defects in title; risks relating to inadequate insurance or inability to obtain insurance; risks related to potential litigation; risks related to the global economy; risks related to the Company’s status as a foreign private issuer in the United States; risks related to all of the Company’s properties being located in Mexico and El Salvador, including political, economic, social and regulatory instability; and risks related to officers and directors becoming associated with other natural resource companies which may give rise to conflicts of interests. Should one or more of these risks and uncertainties materialize, or should underlying assumptions prove incorrect, actual results may vary materially from those described in the forward-looking statements. The Company’s forward-looking statements are based on beliefs, expectations and opinions of management on the date the statements are made. For the reasons set forth above, investors should not place undue reliance on forward-looking statements.
The information provided in this news release is not intended to be a comprehensive review of all matters and developments concerning the Company. It should be read in conjunction with all other disclosure documents of the Company. The information contained herein is not a substitute for detailed investigation or analysis. No securities commission or regulatory authority has reviewed the accuracy or adequacy of the information presented.
Contact:
Fred Cooper (Investor Relations)
J. Scott Drever (CEO)
Telephone: (604) 694-1730
Fax: (604) 694-1761
Toll Free: 1-866-691-1730
Email: info@silvercrestmines.com
Website: www.silvercrestmines.com
Address: Suite 501 - 570 Granville Street
Vancouver, BC Canada V6C 3P1
Published at Investorideas.com Newswire
Disclaimer / Disclosure : The Investorideas.com is a third party publisher of news and research Our sites do not make recommendations, but offer information portals to research news, articles, stock lists and recent research. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. This site is currently compensated by featured companies, news submissions and online advertising. Disclosure: SilverCrest Mines has compensated Investorideas.com for the distribution and publishing of this news release (annual news publication 9700) http://www.investorideas.com/About/Disclaimer.asp
BC Residents and Investor Disclaimer : Effective September 15 2008 - all BC investors should review all OTC and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar. Read for more info: http://www.bcsc.bc.ca/release.aspx?id=6894

March 11th New York Security Conference: Investorideas.com Releases Final Video Presentation – Panel Discussion 'Performance and Investing Opportunities in Security and Defense Companies'

New York, NY - March 12, 2014 (www.investorideas.com newswire) Investorideas.com, an investor research and news portal covering leading sectors including technology and defense, releases the final video presentation from the Security and Defense Conference, "Game Changing Technologies: The Face and Future of Security", held both live in New York and online on March 11, 2014.

Performance and Investing opportunities in Security and Defense Companies
This panel of financial experts examines recent trends on the financial landscape of the industry, the performance of various investment opportunities in the sector, and how to position your company properly for investment and growth.
MODERATOR: SCOTT GREIPER, Secure Strategy Group
Mr. Greiper is the President and Founding Partner of Secure Strategy Group. He has had a distinguished 15-year career in the security and defense technology sectors as both a research analyst and investment banker, and is known as a thought leader in the industry. Before forming Secure Strategy Group, he was a Managing Director at Legend Merchant Group and Head of the firm's Convergent Security Group, which provided capital, strategic advisory and M&A services to growth companies in the security and defense technology markets. Previously, Mr. Greiper was a Principal and Senior Analyst at C. E. Unterberg, Towbin, where he covered public companies in the Global Security industry and was consistently ranked as one of the top analysts in the sector. He has worked with a range of industry leaders and is a frequent guest speaker and moderator at conferences and seminars across the country. Mr. Greiper attended the Executive MBA program at Columbia University and holds a B. A. in Economics from The University of Chicago. He is a member of the FBI InfraGard program, BENS (Business Executives for National Security), ASIS (American Society for Industrial Security) and NYSSA (New York Society for Security Analysts).
PANELISTS: SCOTT SACKNOFF, SPADE Indexes; KRIS TUTTLE, Soundview Technology Group; MANISH THAKUR, Hudson Fairfax Group; PHIL AGCAOLI, Cloud Security Alliance
Mr. Scott Sacknoff is the Index Manager of the SPADE Defense Index (NYSE: ^DXS), the underlying index for the Powershares Aerospace & Defense ETF (NYSE: PPA). The SPADE® Defense Index (NYSE: ^DXS) is a modified capitalization-weighted index comprised of publicly traded companies that benchmarks the performance of companies involved with defense, homeland security, and space. The Index is composed of more than 50 firms with representative business activities including: naval vessels, military aircraft, missiles and munitions, battlespace awareness, C4ISR, network centric warfare, homeland security including border security and biometric and screening systems, and space systems. Index values are distributed by the NYSEarca under the ticker 'DXS'. The Powershares Aerospace & Defense Portfolio ETF, designed to track the SPADE Defense Index, trades under the ticker 'PPA'. Historical data for the Index is available from 30 December 1997. The ETF was launched on 26 October 2005 and is highly liquid.
Kris Tuttle is the Director of Research for SoundView Technology Group which focuses on researching and analyzing emerging public companies in new technology areas. Kris has 35 years of active participation in computing technologies including as an early designer and programmer of microcomputers, a researcher building artificial intelligence applications at Carnegie Mellon University and a career at IBM applying a range of advanced technologies to the most challenging business applications faced by Fortune 500 companies.
Starting in 1992 he has been applying this background to technology stock investing. After the original SoundView was acquired, ultimately by UBS and Charles Schwab, he founded his own firm in 2005 and renamed it SoundView after re-acquiring the SoundView trademarks. Today the firm is focused on advisory services, research and developing more internet-based research and information services.
Kris has a BS in Applied Math/Computer Science from Carnegie Mellon University and an MBA in Finance from the NYU Stern School of Business.
Manish Thakur, is Managing Partner of Hudson Fairfax Group, a strategic investment firm based in New York, Washington and London, focused on cybersecurity, intelligence, big data analytics, and defense private equity. Manish has spent over 20 years covering defense, technology, telecommunications and satellite companies as a principal investor, CFO and investment banker. Before founding HFG, he worked at such firms as Merrill Lynch, SG Cowen and HSBC, where his responsibilities included private equity and strategic investments, initial public offerings, and mergers and acquisitions. Manish also serves as National Security Coordinator for a Capitol Hill-based political action committee. Manish holds an MBA in Finance from Columbia University Graduate School of Business, and a BSc (honors) in Economics from the University of London.
Phil Agcaoili has been an influential leader in the Information Security industry for over 20 years and has established world class security organizations from startups to the Fortune 25. Phil has led successful security teams at General Electric, VeriSign, Alcatel, Scientific Atlanta, Dell, and Cox Communications and was involved in three consecutive and successful startups. He co-founded SecureIT, which he sold to VeriSign for $70, and was VeriSign's first Chief Information Security Officer. He was also an early foundation member of Internet Devices, acquired by Alcatel for $181M. He was the Chief Security Architect for Scientific Atlanta which was acquired by Cisco Systems for $6.9B. Phil participated and influenced the development of the NIST Framework for Improving Critical Infrastructure Cybersecurity. He's shaped Cyber Security for US Telecoms as committee co-chair of the FCC CSRIC and Communications Sector Coordinating Council, and Communications ISAC. He set cloud standards as a founding member of the Cloud Security Alliance (CSA) and is co-founder/author of Cloud Controls Matrix (CCM), Cloud Security Trust, and Assurance Registry (STAR) and Open Certification Framework, aligned security and privacy attestations with the AICPA for SOC 2 attestations (the replacement for SAS 70 attestations), set eDiscovery standards with EDRM, and is a privacy and trust leader as a Ponemon Institute Distinguished Fellow and the Chairman of the Fellows. Phil won the inaugural Information Security Executive of the Decade Award in 2012, 2012 RSA Conference Award for Excellence in the Field of Security Practices, 2010 Information Security Magazine Security 7 Award, and 2009 Information Security Executive of the Year Central Award. Many of Phil's team leaders have started their own companies or they have gone on to lead other successful global security teams.
Videos available at http://www.investorideas.com/Conference/Companies.asp
Where:
http://live.investorideas.com/Event/Investorideascom_Security_and_Defense_Conference
Conference info:
http://www.investorideas.com/Conference/
Media Partners:
Media partners include www.SecuritySolutionsWatch.com, a breaking news site covering new security solutions and business trends; SecurityStockWatch.com for investors following the sector; www.Wallstreetcalendar.com , informing the institutional investment community; Australian Security Magazine ( http://www.australiansecuritymagazine.com.au/ ); Global Security Finance ( www.globalsecurityfinance.com ), an online daily news and data service covering the physical, cyber and identity security and defense sectors; Hedge Connection ( https://www.hedgeconnection.com ), an interactive, web-based marketing tool available to hedge funds and investors; www.biometricupdate.com and http://www.biometricstechnologywatch.com/.
About InvestorIdeas.com: www.investorideas.com
InvestorIdeas.com is a global news source for investors following leading business sectors including biotech, tech, mining, mobile, energy, water, defense and security, renewable energy, food and beverage stocks and Latin American stocks.
Disclaimer/ Disclosure: The Investorideas.com newswire is a third party publisher of news and research as well as creates original content as a news source. Original content created by investorideas is protected by copyright laws other than syndication rights. Investorideas is a news source on Google news and Linkedintoday plus hundreds of syndication partners. Our site does not make recommendations for purchases or sale of stocks or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investment involves risk and possible loss of investment. This site is currently compensated by featured companies, news submissions, content marketing and online advertising. Contact each company directly for press release questions. Disclosure is posted on each release if required but otherwise the news was not compensated for and is published for the sole interest of our readers. More disclaimer info: http://www.investorideas.com/About/Disclaimer.asp BC Residents and Investor Disclaimer : Effective September 15 2008 - all BC investors should review all OTC and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar. Read for more info: http://www.bcsc.bc.ca/release.aspx?id=6894 . Global investors must adhere to regulations of each country
Presenting Companies Contact info:
Cali Van Zant cvanzant@investorideas.com 800. 665. 0411
Sponsorship info:
Eric Salvarezza esalvarezza@investorideas.com 631. 664. 1311
Media Partners: D. Van Zant dvanzant@investorideas.com 800. 665. 0411
800-665-0411 - Source: www.Investorideas.com
Become an Investorideas.com Member and access our 14 online stock directories 24/7 - defense stocks, technology stocks, mining stocks, oil and gas stocks and more... http://www.investorideas.com/membership/